- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Gail Wilensky Examines the Shift to Value-Based Care
Gail Wilensky PhD, senior fellow at Project HOPE, addresses the shift to value-based care over the years and what can be done to keep moving forward.
Gail Wilensky PhD, senior fellow at Project HOPE, addresses the shift to value-based care over the years and what can be done to keep moving forward.
Transcript
Have you seen progress in the shift to value-based care in the recent years? What efforts do you think are needed to accelerate this shift?
I’ve been very disappointed at how hard and how slow it’s been to shift to value-based care. I think several things are going on. We have too many metrics being used; I think we need to drastically consolidate the number of metrics. It would be helpful to have a smaller set used by various payers not each individual payer coming up with their own and a smaller set at that. It’s clearly harder than we thought it would be to be able to move the needle on this.
I also think it would require that much more the reimbursement be put at risk. You can’t expect, particularly, clinicians to respond to an incentive that has quite small effect on their overall reimbursement, either because it’s a very small percent of the overall reimbursement or they, as a particular type of clinician, don’t have very many of those patients. The institutions, the hospitals seem to respond with relatively small changes, although if you really want to get their attention, you ought to increase that, as well. So, we need to keep at it.
The notion of paying as though quality didn’t differ dramatically and efficiency and price didn’t differ dramatically across different institutions is just wrong. We just haven’t figured out how to get it right yet.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
